Skip to main content
. 2019 Jun 2;10(12):2619–2627. doi: 10.7150/jca.32817

Figure 3.

Figure 3

Expression level of WNT6 in different clinical risk scores (CRS) patients and patients with or without preoperative chemotherapy. (A) The expression level of WNT6 was comparable in different CRS patients (P = 0.995). (B) The expression level of WNT6 was significantly lower in patients with preoperative chemotherapy than in those without preoperative chemotherapy (P = 0.003).